Skip to main content
. 2018 Jul 18;13:4209–4226. doi: 10.2147/IJN.S163858

Figure 8.

Figure 8

In vivo antitumor activity of different DOX-loaded formulations.

Note: (A) Tumor volume, (B) body weight, (C) IR (%) and (D) the images of tumor section of different drug-treated groups (n=6).

Abbreviations: DOX, doxorubicin; DQA, dequalinium; IR, inhibition rate; HPS, HER-2 peptide-PEG2000-Schiff base.